JP2023520506A5 - - Google Patents

Info

Publication number
JP2023520506A5
JP2023520506A5 JP2022560168A JP2022560168A JP2023520506A5 JP 2023520506 A5 JP2023520506 A5 JP 2023520506A5 JP 2022560168 A JP2022560168 A JP 2022560168A JP 2022560168 A JP2022560168 A JP 2022560168A JP 2023520506 A5 JP2023520506 A5 JP 2023520506A5
Authority
JP
Japan
Prior art keywords
approximately
nucleic acid
pharmaceutical composition
nanoparticle
protein
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2022560168A
Other languages
English (en)
Japanese (ja)
Other versions
JP2023520506A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2021/025222 external-priority patent/WO2021202772A1/en
Publication of JP2023520506A publication Critical patent/JP2023520506A/ja
Publication of JP2023520506A5 publication Critical patent/JP2023520506A5/ja
Pending legal-status Critical Current

Links

JP2022560168A 2020-04-01 2021-03-31 Sars-cov-2に対する多層rnaナノ粒子ワクチン Pending JP2023520506A (ja)

Applications Claiming Priority (7)

Application Number Priority Date Filing Date Title
US202063003766P 2020-04-01 2020-04-01
US63/003,766 2020-04-01
US202063022999P 2020-05-11 2020-05-11
US63/022,999 2020-05-11
US202063128600P 2020-12-21 2020-12-21
US63/128,600 2020-12-21
PCT/US2021/025222 WO2021202772A1 (en) 2020-04-01 2021-03-31 Multilamellar rna nanoparticle vaccine against sars-cov-2

Publications (2)

Publication Number Publication Date
JP2023520506A JP2023520506A (ja) 2023-05-17
JP2023520506A5 true JP2023520506A5 (https=) 2024-03-22

Family

ID=75625672

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2022560168A Pending JP2023520506A (ja) 2020-04-01 2021-03-31 Sars-cov-2に対する多層rnaナノ粒子ワクチン

Country Status (6)

Country Link
US (1) US20230226169A1 (https=)
EP (1) EP4126030A1 (https=)
JP (1) JP2023520506A (https=)
AU (1) AU2021247163A1 (https=)
CA (1) CA3174187A1 (https=)
WO (1) WO2021202772A1 (https=)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP7783628B2 (ja) * 2019-07-19 2025-12-10 ユニバーシティ オブ フロリダ リサーチ ファンデーション インコーポレーティッド 多層rnaナノ粒子
IL297419B2 (en) 2020-04-22 2025-02-01 BioNTech SE Coronavirus vaccine
WO2022008973A2 (en) * 2020-07-10 2022-01-13 Covid Diagnostics Ltd. Compositions, methods, and systems for detecting immune response
JP2023536962A (ja) * 2020-08-06 2023-08-30 エフ. ホフマン-ラ ロシュ アーゲー 重症急性呼吸器症候群コロナウイルス2(sars-2)、インフルエンザa及びインフルエンザbの検出のための組成物及び方法
IL303434A (en) * 2020-12-07 2023-08-01 Tufts College Lipidoid preparations and methods of using them
US12186387B2 (en) 2021-11-29 2025-01-07 BioNTech SE Coronavirus vaccine
WO2024010686A2 (en) * 2022-06-20 2024-01-11 The Trustees Of Columbia University In The City Of New York Vaccine tissue assays
WO2024002985A1 (en) 2022-06-26 2024-01-04 BioNTech SE Coronavirus vaccine
WO2025089649A1 (ko) * 2023-10-26 2025-05-01 주식회사 차백신연구소 양이온성 리포좀을 포함하는 핵산 전달용 조성물 및 그의 용도

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5795587A (en) 1995-01-23 1998-08-18 University Of Pittsburgh Stable lipid-comprising drug delivery complexes and methods for their production
KR101766408B1 (ko) 2009-06-10 2017-08-10 알닐람 파마슈티칼스 인코포레이티드 향상된 지질 조성물
US8802863B2 (en) 2010-05-24 2014-08-12 Sirna Therapeutics, Inc. Amino alcohol cationic lipids for oligonucleotide delivery
DK2575767T3 (en) 2010-06-04 2017-03-13 Sirna Therapeutics Inc HOWEVER UNKNOWN LOW MOLECULAR CATIONIC LIPIDS TO PROCESS OIGONUCLEOTIDES
CA2841047A1 (en) * 2011-07-06 2013-01-10 Novartis Ag Immunogenic compositions and uses thereof
EP2858679B2 (en) * 2012-06-08 2024-06-05 Translate Bio, Inc. Pulmonary delivery of mrna to non-lung target cells
CN107073028A (zh) * 2013-12-13 2017-08-18 南洋理工大学 多层纳米颗粒及其制作方法和使用方法
US20220233568A1 (en) * 2017-10-19 2022-07-28 Curevac Ag Novel artificial nucleic acid molecules
US10979132B2 (en) * 2018-08-10 2021-04-13 Qualcomm Incorporated Organization of inter-relay discovery reference signals
JP7783628B2 (ja) * 2019-07-19 2025-12-10 ユニバーシティ オブ フロリダ リサーチ ファンデーション インコーポレーティッド 多層rnaナノ粒子
US12194089B2 (en) * 2020-02-04 2025-01-14 CureVac SE Coronavirus vaccine

Similar Documents

Publication Publication Date Title
JP2023520506A5 (https=)
US20220370370A1 (en) Lipid nanoparticles comprising lipophilic anti-inflammatory agents and methods of use thereof
Purohit et al. Interaction of cationic partial dendrimers with charged and neutral liposomes
US7037520B2 (en) Reversible masking of liposomal complexes for targeted delivery
CN114716355B (zh) 一种脂质化合物、包含其的组合物及应用
CN116672316B (zh) 一种核酸-脂质纳米颗粒冻干制剂及其制备方法
CN110522918A (zh) 靶向元件及其制备方法和运用
CN102336802B (zh) 甘草次酸修饰脂质、肝靶向脂质体、胶束及复合物和制法
JP2023512707A5 (https=)
Rodriguez-Gascon et al. Vaginal gene therapy
CN114404391B (zh) 一种纳米粒及其制备方法和用途
JP2025138644A5 (https=)
CN115784920B (zh) 一种转染效率高的可电离脂质化合物及其应用
JP2014506918A (ja) 抗腫瘍活性物質を含むリポソーム製剤、その調製のための方法、及び、それを含む医薬組成物
AU2020269626A1 (en) Method for production of liposomes
CN115087437A (zh) 脂质组合物及其用于将治疗活性剂递送至内皮的用途
CN118267376A (zh) 一种核酸递送载体及其制备方法和用途
Shanmugam et al. Nanostructured self assembled lipid materials for drug delivery and tissue engineering
Talebi et al. The emerging applications of niosome as a nanotechnology-based approach in vaccine delivery
CN114848831A (zh) 包裹型纳米制剂及其载体的制备方法和应用
WO2024205498A1 (en) Nanoparticle-based nucleic acid delivery system
CN116549667B (zh) 一种pas修饰的脂质纳米粒、包含其的药物制剂,及其制备方法和用途
CN118178664A (zh) 一种用于核酸递送的脂质材料及其用途
CN116063205B (zh) 一种含烷基化氨基甲酸酯键的脂质化合物及其应用
WO2024108740A1 (zh) 适合于肌注给药的核酸-脂质纳米颗粒、制剂及其应用